Stratos Wealth Partners’s Emergent Biosolutions EBS Stock Holding History

Stratos Wealth Partners’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-24,400	Closed	-$156K	–	1562
2025 Q2	$156K	Buy	+24,400	New	+$140K	﹤0.01%	1358
2018 Q4	–	Sell	-24	Closed	-$2K	–	1242
2018 Q3	$2K	Buy	+24	New	+$1.4K	﹤0.01%	2683
2018 Q2	–	Sell	-2,541	Closed	-$134K	–	1381
2018 Q1	$134K	Buy	+2,541	New	+$127K	0.01%	1052

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Stratos Wealth Partners's EBS Position: Q3 2025 in Review

Stratos Wealth Partners sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 24,400 shares — an estimated $156K sold.

Stratos Wealth Partners first reported a position in EBS in Q1 2018 and held it in 3 quarters. The position peaked at $156K in Q2 2025. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

Stratos Wealth Partners reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
Stratos Wealth Partners sold 24,400 Emergent Biosolutions shares in Q3 2025, an estimated $156K.
Stratos Wealth Partners first reported a position in Emergent Biosolutions in Q1 2018 and held it in 3 quarters.
Stratos Wealth Partners's Emergent Biosolutions position peaked at $156K in Q2 2025.
169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on Stratos Wealth Partners's 13F filing for Q3 2025, filed 6 Nov 2025.